← Back to Search

Procedure

Fractional Photothermolysis for Alopecia

Phase < 1

Waitlist Available

Research Sponsored by University of California, Irvine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

No evidence of spontaneous hair growth

Must be between the ages of 18 to 90 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial is being done to see if fractional photothermolysis using different lasers can help stimulate hair growth in people with scalp alopecia.

Who is the study for?

This trial is for people aged 18 to 90 with alopecia on the scalp, specifically at the frontal hairline. Participants should be in good health, have not received other hair loss treatments in the past month, and must commit to following the study protocol. Those with a healthy scalp without tumors are eligible; both scarring and non-scarring alopecia are acceptable.

What is being tested?

The study tests fractional photothermolysis (laser resurfacing) using two types of lasers: Fraxel DUAL 1550 or Halo by Sciton. It aims to stimulate hair growth through skin rejuvenation. Fifty subjects will receive treatment up to ten times over several weeks, with one side of their head treated and the other as control.

What are the potential side effects?

Fractional laser treatment may cause minor side effects such as redness, swelling, heat sensation or discomfort at the site of application. The procedure involves heating skin tissue which can lead to rapid cell death but usually heals quickly with few adverse effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have not experienced any unexpected hair regrowth.

Select...

I am between 18 and 90 years old.

Select...

I have been diagnosed with scalp hair loss by a dermatologist.

Select...

My scalp is healthy and cancer-free.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Hair regrowth by dermoscopy

Hair regrowth by optical coherence tomography (OCT).

Secondary study objectives

Hair regrowth impact on Quality of Life

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Halo Hybrid Laser 1550 nmExperimental Treatment1 Intervention

The Halo laser will be used per protocol due to the dynamic thermal optimization technology for hair regrowth. 25 patients with alopecia will be part of this group.

Group II: Fraxel DUAL 1550 nmExperimental Treatment1 Intervention

The Fraxel DUAL 1550 nm laser will be used at 7 mJ, 8 pulses, 120 spots/cm2, treatment level 3 (9% coverage) for hair regrowth. 25 patients with alopecia will be part of this group.

0 / 4Eligibility criteria met